Molecules2

Search for:

Unit 6-10
Zeus Building
Rutherford Avenue
Harwell OX11 0DF
United Kingdom

T: +44 (0)1865 818808

Home
About
Sitemap
Privacy Policy
Privacy Notice
Careers
Contact

Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company focused on the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer.

Molecules2

Archives

Barinthus Biotherapeutics plc